| Enteral versus parenteral nutritional support in allogeneic haematopoietic stem-cell transplantation R Guièze, R Lemal, A Cabrespine, E Hermet, O Tournilhac, C Combal, ... Clinical nutrition 33 (3), 533-538, 2014 | 127 | 2014 |
| Prevalence of malnutrition in adult patients previously treated with allogeneic hematopoietic stem-cell transplantation T Brotelle, R Lemal, A Cabrespine, C Combal, E Hermet, A Ravinet, ... Clinical Nutrition 37 (2), 739-745, 2018 | 51 | 2018 |
| Could enteral nutrition improve the outcome of patients with haematological malignancies undergoing allogeneic haematopoietic stem cell transplantation? A study protocol for a … R Lemal, A Cabrespine, B Pereira, C Combal, A Ravinet, E Hermet, ... Trials 16, 1-9, 2015 | 43 | 2015 |
| Impact of uncontrolled freezing and long-term storage of peripheral blood stem cells at− 80 C on haematopoietic recovery after autologous transplantation. Report from two centres G Detry, L Calvet, N Straetmans, A Cabrespine, C Ravoet, JO Bay, ... Bone Marrow Transplantation 49 (6), 780-785, 2014 | 43 | 2014 |
| Prevalence of chemotherapy-induced peripheral neuropathy in multiple myeloma patients and its impact on quality of life: a single center cross-sectional study M Selvy, N Kerckhove, B Pereira, F Barreau, D Nguyen, J Busserolles, ... Frontiers in Pharmacology 12, 637593, 2021 | 39 | 2021 |
| Circulating chromogranin a and hormone refractory prostate cancer chemotherapy A Cabrespine, L Guy, F Gachon, H Curé, P Chollet, JO Bay The Journal of urology 175 (4), 1347-1352, 2006 | 39 | 2006 |
| Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular … E Hermet, A Cabrespine, R Guieze, A Garnier, A Tempescul, P Lenain, ... Journal of geriatric oncology 6 (5), 346-352, 2015 | 35 | 2015 |
| Randomized phase II study comparing paclitaxel and carboplatin versus mitoxantrone in patients with hormone-refractory prostate cancer A Cabrespine, L Guy, E Khenifar, H Curé, J Fleury, F Penault-Llorca, ... Urology 67 (2), 354-359, 2006 | 30 | 2006 |
| Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a− 80 C mechanical freezer and … L Calvet, A Cabrespine, N Boiret‐Dupré, E Merlin, C Paillard, M Berger, ... Transfusion 53 (3), 570-578, 2013 | 28 | 2013 |
| Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment A Cabrespine-Faugeras, M Bayet-Robert, JO Bay, P Chollet, ... Nutrition and cancer 62 (2), 148-153, 2010 | 26 | 2010 |
| Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis S Lissandre, JO Bay, JY Cahn, R Porcher, V Cacheux, A Cabrespine, ... Bone Marrow Transplantation 46 (4), 557-561, 2011 | 24 | 2011 |
| In vitro assessment of cytotoxic agent combinations for hormone-refractory prostate cancer treatment A Cabrespine, JO Bay, C Barthomeuf, H Curé, P Chollet, E Debiton Anti-Cancer Drugs 16 (4), 417-422, 2005 | 24 | 2005 |
| Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A … A Ravinet, A Cabrespine, G Socié, N Milpied, IY Agha, S Nguyen, ... Transplantation 100 (8), 1732-1739, 2016 | 19 | 2016 |
| Molecular mechanisms involved in hormone resistance of prostate cancer A Cabrespine, L Guy, P Chollet, É Debiton, JO Bay Bulletin du Cancer 91 (10), 747-757, 2004 | 19 | 2004 |
| Allogeneic hematopoietic stem cell transplantation in ovarian cancer—the EBMT experience JO Bay, A Cabrespine‐Faugeras, R Tabrizi, D Blaise, P Viens, ... International journal of cancer 127 (6), 1446-1452, 2010 | 18 | 2010 |
| Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study B de Renzis, V Mansat-De Mas, E Wattel, O Beyne-Rauzy, L Knoops, ... Leukemia research reports 2 (2), 64-66, 2013 | 15 | 2013 |
| Interleukin-6 implication in prostate cancer A Cabrespine, JO Bay, P Verrelle, L Morel Bulletin du Cancer 94 (4), 29-34, 2007 | 12 | 2007 |
| Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of … O Tournilhac, M Le Garff-Tavernier, SN Quoc, E Forcade, P Chevallier, ... haematologica 106 (7), 1867, 2021 | 11 | 2021 |
| Impact of ATG dose on the outcome of patients undergoing reduced intensity conditioning followed by allogeneic hematopoietic stem cell transplantation for hematological … J Cornillon, M Balsat, A Cabrespine, E Tavernier-Tardy, E Hermet, ... Acta Haematologica 136 (4), 193-200, 2016 | 11 | 2016 |
| Hematopoietic Stem Cell Transplantation (HSCT) in Waldenström Macroglobulinemia (Wm), Update of the French Experience in 54 Cases. N Dhedin, R Tabrizi, PE Bulabois, S Le Gouill, V Coiteux, C Dartigeas, ... Blood, The Journal of the American Society of Hematology 110 (11), 3015-3015, 2007 | 11 | 2007 |
